Yuanyuan Guo

2.1k total citations · 1 hit paper
73 papers, 1.5k citations indexed

About

Yuanyuan Guo is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Yuanyuan Guo has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Yuanyuan Guo's work include Cancer-related molecular mechanisms research (6 papers), Viral-associated cancers and disorders (5 papers) and Aortic aneurysm repair treatments (4 papers). Yuanyuan Guo is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), Viral-associated cancers and disorders (5 papers) and Aortic aneurysm repair treatments (4 papers). Yuanyuan Guo collaborates with scholars based in China, United States and Czechia. Yuanyuan Guo's co-authors include Meijuan Chen, Guo‐Liang Wang, WU Wen-xi, Wei De, Jinhai Li, Ming Sun, Yutao Wang, Suli Zhang, Bei Cui and Robert A. Brenes and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Yuanyuan Guo

66 papers receiving 1.5k citations

Hit Papers

4D Printed Cardiac Occlusion Device with Efficient Antico... 2025 2026 2025 5 10 15 20

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanyuan Guo China 22 605 248 242 239 221 73 1.5k
Ziyu Wang China 27 649 1.1× 294 1.2× 254 1.0× 130 0.5× 195 0.9× 139 2.0k
Pei‐Wen Wang Taiwan 25 595 1.0× 162 0.7× 303 1.3× 275 1.2× 228 1.0× 77 1.7k
Ying Yue China 21 568 0.9× 272 1.1× 295 1.2× 230 1.0× 131 0.6× 76 1.6k
Kai Guo China 27 780 1.3× 132 0.5× 273 1.1× 250 1.0× 179 0.8× 109 2.2k
Jiawei Chen China 23 534 0.9× 232 0.9× 133 0.5× 112 0.5× 167 0.8× 128 1.5k
Hai Zou China 21 546 0.9× 299 1.2× 189 0.8× 146 0.6× 137 0.6× 76 1.6k
Yimeng Wang China 23 896 1.5× 208 0.8× 235 1.0× 535 2.2× 134 0.6× 138 2.0k
Lan Bai China 24 743 1.2× 347 1.4× 191 0.8× 226 0.9× 156 0.7× 101 1.7k
Yuanhua Liu China 26 790 1.3× 131 0.5× 131 0.5× 211 0.9× 166 0.8× 87 1.7k
Yuchen Zhang China 27 977 1.6× 241 1.0× 574 2.4× 269 1.1× 206 0.9× 134 2.4k

Countries citing papers authored by Yuanyuan Guo

Since Specialization
Citations

This map shows the geographic impact of Yuanyuan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Guo more than expected).

Fields of papers citing papers by Yuanyuan Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyuan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Guo. The network helps show where Yuanyuan Guo may publish in the future.

Co-authorship network of co-authors of Yuanyuan Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanyuan Guo. A scholar is included among the top collaborators of Yuanyuan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanyuan Guo. Yuanyuan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yuanyuan, et al.. (2025). MiR-147b-3p promotes osteogenesis by targeting NDUFA4 and PI3K/AKT pathway. Journal of Orthopaedic Surgery and Research. 20(1). 235–235. 1 indexed citations
2.
Liu, Li, Xianling Wang, Xiaohong Chen, et al.. (2025). Epimedium brevicornu Maxim. extract activates natural killer cells against hepatocellular carcinoma via the cGAS-STING pathway. Frontiers in Pharmacology. 16. 1681650–1681650.
3.
Wang, Xin, Jie Zhang, Yuanyuan Guo, et al.. (2024). Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents. Signal Transduction and Targeted Therapy. 9(1). 160–160. 2 indexed citations
4.
Dai, Jiyan, Suqin Li, Xinzheng Jia, et al.. (2024). Expression patterns of interleukin-6 and microRNA-146A during orthodontic relapse in a rat model.. PubMed. 75(4). 1 indexed citations
5.
Guo, Yuanyuan, et al.. (2024). Bibliometric and visualization analysis of the application of inorganic nanomaterials to autoimmune diseases. Biomaterials Science. 12(16). 3981–4005. 4 indexed citations
6.
Zhang, Jianing, Can Yue, Lin Yin, et al.. (2024). Uncommon P1 Anchor-featured Viral T Cell Epitope Preference within HLA-A*2601 and HLA-A*0101 Individuals. ImmunoHorizons. 8(6). 415–430. 2 indexed citations
7.
Fang, Yan, Yuanyuan Guo, Rui Yang, et al.. (2024). Cytochrome P450 2E1 inhibitor Q11 is effective on hepatocellular carcinoma by promoting peritumor neutrophil chemotaxis. International Journal of Biological Macromolecules. 293. 139189–139189. 1 indexed citations
8.
Guo, Yuanyuan, Tiansong Xu, Yujuan Chai, & Feng Chen. (2023). TGF-β Signaling in Progression of Oral Cancer. International Journal of Molecular Sciences. 24(12). 10263–10263. 12 indexed citations
9.
Xu, Ziqian, et al.. (2023). A black goat-derived novel genotype of Aichi virus C blurs the boundary between caprine and porcine kobuviruses. Virology. 585. 215–221. 1 indexed citations
10.
Guo, Yuanyuan, Zhiquan Li, Feng Chen, & Yujuan Chai. (2023). Polyphenols in Oral Health: Homeostasis Maintenance, Disease Prevention, and Therapeutic Applications. Nutrients. 15(20). 4384–4384. 29 indexed citations
11.
Ren, Kaidi, Yuanyuan Guo, Han Xing, et al.. (2023). Regulated necrosis pathways: a potential target for ischemic stroke. Burns & Trauma. 11. tkad016–tkad016. 21 indexed citations
12.
Guo, Yuanyuan, Fengyuan Gao, Adeel Ahmed, et al.. (2023). Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies. Journal of Materials Chemistry B. 11(36). 8586–8604. 20 indexed citations
13.
Ye, Beiwei, Yaxin Guo, Yuanyuan Guo, et al.. (2022). Repeated influenza vaccination induces similar immune protection as first‐time vaccination but with differing immune responses. Influenza and Other Respiratory Viruses. 17(1). e13060–e13060. 5 indexed citations
14.
15.
16.
Guo, Yuanyuan, Rong Yin, Dingji Shi, et al.. (2017). Effect of Anabaena-expressed VP28 against white spot syndrome virus and related immune response in Litopenaeus vannamei.. JOURNAL OF FISHERIES OF CHINA. 41(9). 1473–1485. 1 indexed citations
17.
Zhu, Dan, Yuanyuan Guo, Junlian Li, et al.. (2015). Intracameral Interleukin 1β, 6, 8, 10, 12p, Tumor Necrosis Factor α and Vascular Endothelial Growth Factor and Axial Length in Patients with Cataract. PLoS ONE. 10(2). e0117777–e0117777. 20 indexed citations
18.
Guo, Yuanyuan, et al.. (2014). Effect of paclitaxel on proliferation of human Tenon fibroblast and its probably mechanism. Zhonghua shiyan yanke zazhi. 32(2). 119–124. 1 indexed citations
19.
Xue, Min, Yuanyuan Guo, Qin Yan, Di Qin, & Lu Chun. (2013). Preparation and application of polyclonal antibodies against KSHV v-cyclin. Journal of Biomedical Research. 27(5). 421–421. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026